Genome-wide association study of pathological gambling

European Psychiatry

Volumn 36, Issue , 2016, Pages 38-46

  Lang, M ^a   Lemenager T ^a   Streit, F ^a   Fauth Buhler M ^a   Frank, J ^a   Juraeva, D ^b   Witt, S H ^a   Degenhardt, F ^c   Hofmann, A ^c   Heilmann Heimbach, S ^c   Kiefer, F ^a   Brors, B ^b   Grabe, H J ^e,f   John, U ^e,l   Bischof, A ^g   Bischof, G ^g   Volker U ^e,l   Homuth, G ^e   Beutel, M ^m   Lind, P A ^d   Medland, S E ^d   Slutske, W S ^h   Martin, N G ^d   Volzke H ^i,k   Nothen M M ^c   Meyer, C ^e,l   Rumpf, H J ^g   Wurst, F M ^j,m   Rietschel, M ^a   Mann, K F ^a   more..

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g UNIVERSITY OF LÜBECK   (Germany)

^h UNIVERSITY OF MISSOURI   (United States)

ⁱ UNIVERSITY OF GREIFSWALD   (Germany)

^j UNIVERSITY OF HAMBURG   (Germany)

^k DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^l Kraichtal Kliniken   (Germany)

^m PARACELSUS MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

Addiction; Association; Gambling; Genetics; Genome wide

Indexed keywords

ADENOSINE PHOSPHATE; PROTEIN KINASE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; APOPTOSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ANALYSIS; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SIGNAL TRANSDUCTION; ADDICTION; DRUG DEPENDENCE; GAMBLING; GENETICS; MIDDLE AGED; PSYCHOLOGY;

ADULT; ALCOHOLISM; BEHAVIOR, ADDICTIVE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GAMBLING; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMANS; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS;

EID: 84973912640     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.04.001     Document Type: Article

References (57)

1. Lupi M., Martinotti G., Acciavatti T., Pettorruso M., Brunetti M., Santacroce R., et al. Pharmacological treatments in gambling disorder: a qualitative review. BioMed Res Int 2014, 2014:537306. 10.1155/2014/537306.
2. Sassen M., Kraus L., Bühringer G. Differences in pathological gambling prevalence estimates: facts or artefacts?. Int J Methods Psychiatr Res 2011, 20:e83-e99. 10.1002/mpr.354.
3. Meyer C., Bischof A., Westram A., Jeske C., de Brito S., Glorius S., et al. The "Pathological Gambling and Epidemiology" (PAGE) study program: design and fieldwork. Int J Methods Psychiatr Res 2015, 24:11-31. 10.1002/mpr.1458.
4. Grant J.E., Potenza M.N., Weinstein A., Gorelick D.A. Introduction to Behavioral Addictions. Am J Drug Alcohol Abuse 2010, 36:233-241. 10.3109/00952990.2010.491884.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association. 5th ed.
6. Fattore L., Melis M., Fadda P., Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol 2014, 35:272-284. 10.1016/j.yfrne.2014.04.003.
7. Barnes G.M., Welte J.W., Tidwell M-CO, Hoffman J.H. Gambling and substance use: co-occurrence among adults in a recent general population study in the United States. Int Gambl Stud 2015, 15:55-71. 10.1080/14459795.2014.990396.
8. Kastirke N., Rumpf H.-J., John U., Bischof A., Meyer C. Demographic risk factors and gambling preference may not explain the high prevalence of gambling problems among the population with migration background: results from a German Nationwide Survey. J Gambl Stud 2014, 10.1007/s10899-014-9459-0.
9. Bagby R.M., Vachon D.D., Bulmash E.L., Toneatto T., Quilty L.C., Costa P.T. Pathological gambling and the five-factor model of personality. Personal Individ Differ 2007, 43:873-880. 10.1016/j.paid.2007.02.011.
10. Lister J.J., Milosevic A., Ledgerwood D.M. Personality traits of problem gamblers with and without alcohol dependence. Addict Behav 2015, 47:48-54. 10.1016/j.addbeh.2015.02.021.
11. Black D.W., Coryell W.H., Crowe R.R., Shaw M., McCormick B., Allen J. Personality disorders, impulsiveness, and novelty seeking in persons with DSM-IV pathological gambling and their first-degree relatives. J Gambl Stud 2014, 10.1007/s10899-014-9505-y.
12. Bischof A., Meyer C., Bischof G., Kastirke N., John U., Rumpf H.-J. Comorbid Axis I-disorders among subjects with pathological, problem, or at-risk gambling recruited from the general population in Germany: results of the PAGE study. Psychiatry Res 2013, 210:1065-1070. 10.1016/j.psychres.2013.07.026.
13. Blanco C., Myers J., Kendler K.S. Gambling, disordered gambling and their association with major depression and substance use: a web-based cohort and twin-sibling study. Psychol Med 2012, 42:497-508. 10.1017/S0033291711001401.
14. Slutske W.S., Eisen S., True W.R., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000, 57:666-673.
15. Slutske W.S., Ellingson J.M., Richmond-Rakerd L.S., Zhu G., Martin N.G. Shared genetic vulnerability for disordered gambling and alcohol use disorder in men and women: evidence from a National Community-Based Australian Twin Study. Twin Res Hum Genet 2013, 16:525-534. 10.1017/thg.2013.11.
16. Slutske W.S., Zhu G., Meier M.H., Martin N.G. Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry 2010, 67:624-630. 10.1001/archgenpsychiatry.2010.51.
17. Slutske W.S., Meier M.H., Zhu G., Statham D.J., Blaszczynski A., Martin N.G. The Australian Twin Study of Gambling (OZ-GAM): rationale, sample description, predictors of participation, and a first look at sources of individual differences in gambling involvement. Twin Res Hum Genet 2009, 12:63-78. 10.1375/twin.12.1.63.
18. Eisen S.A., Slutske W.S., Lyons M.J., Lassman J., Xian H., Toomey R., et al. The genetics of pathological gambling. Semin Clin Neuropsychiatry 2001, 6:195-204.
19. Slutske W.S., Richmond-Rakerd L.S. A closer look at the evidence for sex differences in the genetic and environmental influences on gambling in the National Longitudinal Study of Adolescent health: from disordered to ordered gambling: a twin study of gambling in Add Health redux. Addiction 2014, 109:120-127. 10.1111/add.12345.
20. Lind P.A., Zhu G., Montgomery G.W., Madden P.A.F., Heath A.C., Martin N.G., et al. Genome-wide association study of a quantitative disordered gambling trait. Addict Biol 2013, 18:511-522. 10.1111/j.1369-1600.2012.00463.x.
21. Eisenegger C., Knoch D., Ebstein R.P., Gianotti L.R.R., Sándor P.S., Fehr E. Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior. Biol Psychiatry 2010, 67:702-706. 10.1016/j.biopsych.2009.09.021.
22. Lobo D.S.S., Aleksandrova L., Knight J., Casey D.M., el-Guebaly N., Nobrega J.N., et al. Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models. Mol Psychiatry 2015, 20:1002-1010. 10.1038/mp.2014.113.
23. Lobo D.S.S., Souza R.P., Tong R.P., Casey D.M., Hodgins D.C., Smith G.J., et al. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol 2010, 85:33-37. 10.1016/j.biopsycho.2010.04.008.
24. Wilson D., da Silva Lobo D.S., Tavares H., Gentil V., Vallada H. Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci MN 2013, 49:550-553. 10.1007/s12031-012-9846-x.
25. Gyollai A., Griffiths M.D., Barta C., Vereczkei A., Urbán R., Kun B., et al. The genetics of problem and pathological gambling: a systematic review. Curr Pharm Des 2014, 20:3993-3999.
26. Genetics of Disordered Gambling 2013, John Wiley & Sons, Ltd., eLS, Chichester, UK. W.S. Slutske (Ed.).
27. Ibáñez A., Blanco C., Perez de Castro I., Fernandez-Piqueras J., Sáiz-Ruiz J. Genetics of pathological gambling. J Gambl Stud 2003, 19:11-22.
28. Potenza M.N. Neurobiology of gambling behaviors. Curr Opin Neurobiol 2013, 23:660-667. 10.1016/j.conb.2013.03.004.
29. Fauth-Bühler M., Mann K., Potenza M.N. Pathological gambling: a review of the neurobiological evidence relevant for its classification as an addictive disorder. Addict Biol 2016, 10.1111/adb.12378.
30. Takeuchi F., Isono M., Nabika T., Katsuya T., Sugiyama T., Yamaguchi S., et al. Confirmation of ALDH2 as a major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population. Circ J 2011, 75:911-918.
31. Lesieur H.R., Blume S.B. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987, 144:1184-1188.
32. Wittchen H.-U., Zaudig M., Fydrich T. Strukturiertes Klinisches Interview für DSM-IV 1997, Hogrefe, Göttingen.
33. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the study of health in pomerania. Int J Epidemiol 2011, 40:294-307. 10.1093/ije/dyp394.
34. Mishra A., Macgregor S. VEGAS2: software for more flexible gene-based testing. Twin Res Hum Genet 2015, 18:86-91. 10.1017/thg.2014.79.
35. Deelen J., Uh H.-W., Monajemi R., van Heemst D., Thijssen P.E., Böhringer S., et al. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age Dordr Neth 2013, 35:235-249. 10.1007/s11357-011-9340-3.
36. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
37. KEGG n.d. http://www.genome.jp/kegg/pathway.html.
38. Croft D., Mundo A.F., Haw R., Milacic M., Weiser J., Wu G., et al. The reactome pathway knowledgebase. Nucleic Acids Res 2014, 42:D472-D477. 10.1093/nar/gkt1102.
39. Reactome n.d. http://geneontology.org/page/go-database.
40. Gene Ontology Consortium: going forward. Nucleic Acids Res 2015, 43:D1049-D1056. Gene Ontology Consortium. 10.1093/nar/gku1179.
41. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752. 10.1038/nature08185.
42. Frank J., Cichon S., Treutlein J., Ridinger M., Mattheisen M., Hoffmann P., et al. Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol 2012, 17:171-180. 10.1111/j.1369-1600.2011.00395.x.
43. Liinamaa M.J., Hannuksela M.L., Kesäniemi Y.A., Savolainen M.J. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 1997, 17:2940-2947.
44. Mäkelä S.M., Jauhiainen M., Ala-Korpela M., Metso J., Lehto T.M., Savolainen M.J., et al. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles. Alcohol Clin Exp Res 2008, 32:991-1000. 10.1111/j.1530-0277.2008.00660.x.
45. Chasman D.I., Paré G., Mora S., Hopewell J.C., Peloso G., Clarke R., et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 2009, 5:e1000730. 10.1371/journal.pgen.1000730.
46. Inouye M., Ripatti S., Kettunen J., Lyytikäinen L.-P., Oksala N., Laurila P-P., et al. Novel loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 2012, 8:e1002907. 10.1371/journal.pgen.1002907.
47. Lee A.M., Messing R.O. Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens. Proc Natl Acad Sci U S A 2011, 108:16080-16085. 10.1073/pnas.1106277108.
48. Kalkhoven C., Sennef C., Peeters A., van den Bos R. Risk-taking and pathological gambling behavior in Huntington's disease. Front Behav Neurosci 2014, 8:103. 10.3389/fnbeh.2014.00103.
49. Campbell M.C., Stout J.C., Finn P.R. Reduced autonomic responsiveness to gambling task losses in Huntington's disease. J Int Neuropsychol Soc 2004, 10:239-245. 10.1017/S1355617704102105.
50. Busemeyer J.R., Stout J.C. A contribution of cognitive decision models to clinical assessment: decomposing performance on the Bechara gambling task. Psychol Assess 2002, 14:253-262.
51. Brevers D., Koritzky G., Bechara A., Noël X. Cognitive processes underlying impaired decision-making under uncertainty in gambling disorder. Addict Behav 2014, 39:1533-1536. 10.1016/j.addbeh.2014.06.004.
52. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011, 25:1895-1908. 10.1101/gad.17420111.
53. Tomita K., Tamiya G., Ando S., Kitamura N., Koizumi H., Kato S., et al. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res 2005, 29:240S-245S.
54. Ceni E., Mello T., Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol 2014, 20:17756-17772. 10.3748/wjg.v20.i47.17756.
55. Hassan M., Watari H., AbuAlmaaty A., Ohba Y., Sakuragi N. Apoptosis and molecular targeting therapy in cancer. BioMed Res Int 2014, 2014:150845. 10.1155/2014/150845.
56. Quintero G.C. Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatry Dis Treat 2013, 9:1499-1512. 10.2147/NDT.S45963.
57. Slutske W.S., Zhu G., Meier M.H., Martin N.G. Disordered gambling as defined by the Diagnostic and Statistical Manual of Mental Disorders and the South Oaks Gambling Screen: evidence for a common etiologic structure. J Abnorm Psychol 2011, 120:743-751. 10.1037/a0022879.